Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Kidney Research and Clinical Practice
>
2017
>
36
>
3
Volume:
36
Issue:
3
1. The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol.
Page:207—208
2. Treatment of renal anemia: Erythropoiesis stimulating agents and beyond.
Page:209—223
3. A calpain inhibitor protects against fractalkine production in lipopolysaccharide-treated endothelial cells.
Page:224—231
4. Red cell distribution width predicts incident dipstick albuminuria in Korean adults without chronic kidney disease.
Page:232—239
5. The influence of hypophosphatemia on outcomes of low- and high-intensity continuous renal replacement therapy in critically ill patients with acute kidney injury.
Page:240—249
6. Heart rate is associated with mortality in patients undergoing continuous renal replacement therapy.
Page:250—256
7. Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome.
Page:257—263
8. The effects of different physical activities on atrial fibrillation in patients with hypertension and chronic kidney disease.
Page:264—273
9. Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis.
Page:274—281
10. Association of serum uric acid level with coronary artery stenosis severity in Korean end-stage renal disease patients.
Page:282—289
11. Numerical expression of volume status using the bioimpedance ratio in continuous ambulatory peritoneal dialysis patients: A pilot study.
Page:290—295
12. Staphylococcal infection-associated crescentic immunoglobulin A nephropathy.
Page:296—297
